IllustrativeOwkin Unveils AI-Driven Oncology and Immunology Pipeline, In-Licenses Best-in-Class Asset OKN4395
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
Owkin has announced its ai-driven pipeline for oncology and immunology. The company has also in-licensed an asset called okn4395, which is described as best-in-class. This move appears to be part of owkin's efforts in the fields of oncology and immunology.